Author: Suochen Tian; Zhenqin Chang; Yunxia Wang; Min Wu; Wenming Zhang; Guijie Zhou; Xiuli Zou; Hui Tian; Tingfang Xiao; Junmin Xing; Juan Chen; Jian Han; Kang Ning; Tiejun Wu
Title: Clinical characteristics and reasons of different duration from onset to release from quarantine for patients with COVID-19 Outside Hubei province, China. Document date: 2020_3_23
ID: hix00vyd_40
Snippet: The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.03. 21.20038778 doi: medRxiv preprint although there was no specific antiviral drug for COVID-19, systematic supportive treatment after admission could improve outcomes, even in mild and moderate patients. There was no difference in PSI score, chronic underlying disease, epidemiological history on admission between the two groups, possibly due t.....
Document: The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.03. 21.20038778 doi: medRxiv preprint although there was no specific antiviral drug for COVID-19, systematic supportive treatment after admission could improve outcomes, even in mild and moderate patients. There was no difference in PSI score, chronic underlying disease, epidemiological history on admission between the two groups, possibly due to the small number of cases or mild illness.
Search related documents:
Co phrase search for related documents- antiviral drug and chronic underlying disease: 1
- antiviral drug and epidemiological history: 1
- antiviral drug and group admission: 1, 2, 3
- antiviral drug and mild illness: 1, 2, 3, 4, 5, 6
- antiviral drug and moderate mild patient: 1, 2
- antiviral drug and outcome improve: 1
- antiviral drug and small number: 1, 2, 3, 4, 5, 6
- antiviral drug and specific antiviral drug: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68
- antiviral drug and supportive treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- antiviral drug and underlying disease: 1, 2
- chronic underlying disease and epidemiological history: 1
- chronic underlying disease and mild illness: 1, 2, 3
- chronic underlying disease and underlying disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- epidemiological history and group admission: 1
- epidemiological history and group admission epidemiological history: 1
- epidemiological history and mild illness: 1, 2
- epidemiological history and outcome improve: 1
- epidemiological history and small number: 1
- epidemiological history and supportive treatment: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date